back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-01 14:13 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Roy, Christian
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$36,415
+9,583 vol $3.80 each |
41,649 | |
| Filed 2024-04-01 14:11 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$37,262
+9,806 vol $3.80 each |
61,414 | |
| Filed 2024-04-01 14:08 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$16,936
+4,457 vol $3.80 each |
87,293 | |
| Filed 2024-04-01 14:05 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$38,957
+10,252 vol $3.80 each |
120,900 | |
| Filed 2024-04-01 14:03 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$49,118
+12,926 vol $3.80 each |
132,472 | |
| Filed 2024-04-01 13:59 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$21,808
+5,739 vol $3.80 each |
94,635 | |
| Filed 2024-04-01 13:53 Tx date 2024-03-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2024-04-01 13:53 Tx date 2024-03-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,600
+2,000 vol $3.80 each |
2,000 | |
| Filed 2024-04-01 13:52 Tx date 2024-03-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2024-04-01 13:52 Tx date 2024-03-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$720.00
+200 vol $3.60 each |
200 | |
| Filed 2024-04-01 13:51 Tx date 2024-03-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2024-04-01 13:50 Tx date 2024-03-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,735
+5,300 vol $3.72 each |
5,300 | |
| Filed 2024-04-01 13:50 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2024-04-01 13:49 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,405
+5,300 vol $3.85 each |
5,300 | |
| Filed 2024-04-01 13:48 Tx date 2024-03-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2024-04-01 13:48 Tx date 2024-03-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,134
+5,300 vol $3.99 each |
5,300 | |
| Filed 2024-04-01 13:47 Tx date 2024-03-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2024-04-01 13:47 Tx date 2024-03-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,153
+5,300 vol $3.99 each |
5,300 | |
| Filed 2024-04-01 13:46 Tx date 2024-03-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2024-04-01 13:45 Tx date 2024-03-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,169
+5,300 vol $3.99 each |
5,300 | |
| Filed 2024-04-01 13:44 Tx date 2024-03-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-700 vol |
0 | |
| Filed 2024-04-01 13:44 Tx date 2024-03-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,835
+700 vol $4.05 each |
700 | |
| Filed 2024-04-01 13:43 Tx date 2024-03-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,000 vol |
0 | |
| Filed 2024-04-01 13:43 Tx date 2024-03-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,375
+5,000 vol $4.08 each |
5,000 | |
| Filed 2024-04-01 13:42 Tx date 2024-03-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,000 vol |
0 | |
| Filed 2024-04-01 13:41 Tx date 2024-03-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,500
+5,000 vol $4.10 each |
5,000 | |
| Filed 2024-04-01 13:41 Tx date 2024-03-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2024-04-01 13:40 Tx date 2024-03-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,300
+1,000 vol $4.30 each |
1,000 | |
| Filed 2024-04-01 13:40 Tx date 2024-03-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2024-04-01 13:39 Tx date 2024-03-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,100
+500 vol $4.20 each |
500 | |
| Filed 2024-04-01 13:39 Tx date 2024-03-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2024-04-01 13:38 Tx date 2024-03-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,280
+1,000 vol $4.28 each |
1,000 | |
| Filed 2024-04-01 13:38 Tx date 2024-03-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-700 vol |
0 | |
| Filed 2024-04-01 13:37 Tx date 2024-03-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,982
+700 vol $4.26 each |
700 | |
| Filed 2024-03-25 13:54 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Roy, Christian
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$110,184
+27,006 vol $4.08 each |
32,066 | |
| Filed 2024-03-25 13:52 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$203,114
+49,783 vol $4.08 each |
82,836 | |
| Filed 2024-03-25 13:50 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$106,842
+26,187 vol $4.08 each |
26,187 | |
| Filed 2024-03-25 13:50 Tx date 2023-06-21 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-25 13:48 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$203,114
+49,783 vol $4.08 each |
51,608 | |
| Filed 2024-03-25 13:46 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$203,114
+49,783 vol $4.08 each |
110,648 | |
| Filed 2024-03-25 13:43 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$203,114
+49,783 vol $4.08 each |
88,896 | |
| Filed 2024-03-25 13:40 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$217,362
+53,275 vol $4.08 each |
119,546 | |
| Filed 2024-03-04 14:26 Tx date 2024-02-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2024-03-04 14:26 Tx date 2024-02-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,880
+2,000 vol $3.94 each |
2,000 | |
| Filed 2024-03-04 14:25 Tx date 2024-02-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2024-03-04 14:25 Tx date 2024-02-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$398.00
+100 vol $3.98 each |
100 | |
| Filed 2024-03-04 14:24 Tx date 2024-02-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,100 vol |
0 | |
| Filed 2024-03-04 14:24 Tx date 2024-02-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,524
+1,100 vol $4.11 each |
1,100 | |
| Filed 2024-03-04 14:23 Tx date 2024-02-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,700 vol |
0 | |
| Filed 2024-03-04 14:23 Tx date 2024-02-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,999
+2,700 vol $4.07 each |
2,700 | |
| Filed 2024-03-04 14:22 Tx date 2024-02-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2024-03-04 14:22 Tx date 2024-02-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$418.00
+100 vol $4.18 each |
100 | |
| Filed 2024-03-04 14:21 Tx date 2024-02-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2024-03-04 14:21 Tx date 2024-02-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,150
+1,000 vol $4.15 each |
1,000 | |
| Filed 2024-03-04 14:20 Tx date 2024-02-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2024-03-04 14:19 Tx date 2024-02-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$415.00
+100 vol $4.15 each |
100 | |
| Filed 2024-03-04 14:19 Tx date 2024-02-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,500 vol |
0 | |
| Filed 2024-03-04 14:18 Tx date 2024-02-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,450
+2,500 vol $4.18 each |
2,500 | |
| Filed 2024-02-02 12:33 Tx date 2024-01-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,500 vol |
0 | |
| Filed 2024-02-02 12:32 Tx date 2024-01-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,450
+2,500 vol $4.18 each |
2,500 | |
| Filed 2024-02-02 12:32 Tx date 2024-01-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2024-02-02 12:31 Tx date 2024-01-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,420
+2,000 vol $4.21 each |
2,000 | |
| Filed 2024-02-02 12:31 Tx date 2024-01-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,100 vol |
0 | |
| Filed 2024-02-02 12:30 Tx date 2024-01-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,499
+1,100 vol $4.09 each |
1,100 | |
| Filed 2024-02-02 12:30 Tx date 2024-01-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,000 vol |
0 | |
| Filed 2024-02-02 12:29 Tx date 2024-01-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,400
+5,000 vol $4.08 each |
5,000 | |
| Filed 2024-02-02 12:28 Tx date 2024-01-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,100 vol |
0 | |
| Filed 2024-02-02 12:28 Tx date 2024-01-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,488
+1,100 vol $4.08 each |
1,100 | |
| Filed 2024-02-02 12:27 Tx date 2024-01-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2024-02-02 12:27 Tx date 2024-01-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,380
+2,000 vol $4.19 each |
2,000 | |
| Filed 2024-02-02 12:26 Tx date 2024-01-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-400 vol |
0 | |
| Filed 2024-02-02 12:26 Tx date 2024-01-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,684
+400 vol $4.21 each |
400 | |
| Filed 2024-02-02 12:25 Tx date 2024-01-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,100 vol |
0 | |
| Filed 2024-02-02 12:24 Tx date 2024-01-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,697
+2,100 vol $4.14 each |
2,100 | |
| Filed 2024-02-02 12:24 Tx date 2024-01-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,400 vol |
0 | |
| Filed 2024-02-02 12:23 Tx date 2024-01-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,762
+3,400 vol $4.05 each |
3,400 | |
| Filed 2024-02-02 12:22 Tx date 2024-01-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,200 vol |
0 | |
| Filed 2024-02-02 12:21 Tx date 2024-01-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,170
+2,200 vol $4.17 each |
2,200 | |
| Filed 2024-02-02 12:20 Tx date 2024-01-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2024-02-02 12:20 Tx date 2024-01-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,200
+2,000 vol $4.10 each |
2,000 | |
| Filed 2024-02-02 12:19 Tx date 2024-01-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2024-02-02 12:18 Tx date 2024-01-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,709
+5,300 vol $4.10 each |
5,300 | |
| Filed 2024-02-02 12:17 Tx date 2024-01-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,307 vol |
0 | |
| Filed 2024-02-02 12:17 Tx date 2024-01-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,899
+5,307 vol $4.31 each |
5,307 | |
| Filed 2024-02-02 12:16 Tx date 2024-01-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,100 vol |
0 | |
| Filed 2024-02-02 12:15 Tx date 2024-01-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,659
+2,100 vol $4.12 each |
2,100 | |
| Filed 2024-01-05 09:29 Tx date 2023-12-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,700 vol |
0 | |
| Filed 2024-01-05 09:29 Tx date 2023-12-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,929
+3,700 vol $4.03 each |
3,700 | |
| Filed 2024-01-05 09:28 Tx date 2023-12-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2024-01-05 09:27 Tx date 2023-12-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,905
+5,300 vol $3.94 each |
5,300 | |
| Filed 2024-01-05 09:27 Tx date 2023-12-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,500 vol |
0 | |
| Filed 2024-01-05 09:26 Tx date 2023-12-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2024-01-05 09:26 Tx date 2023-12-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,764
+3,500 vol $3.65 each |
3,500 | |
| Filed 2024-01-05 09:25 Tx date 2023-12-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,875
+5,300 vol $3.75 each |
5,300 | |
| Filed 2024-01-05 09:24 Tx date 2023-12-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2024-01-05 09:23 Tx date 2023-12-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,500
+1,000 vol $3.50 each |
1,000 | |
| Filed 2024-01-05 09:23 Tx date 2023-12-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,000 vol |
0 | |
| Filed 2024-01-05 09:22 Tx date 2023-12-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,993
+5,000 vol $3.60 each |
5,000 | |
| Filed 2024-01-05 09:21 Tx date 2023-12-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,800 vol |
0 | |
| Filed 2024-01-05 09:21 Tx date 2023-12-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,506
+3,800 vol $3.82 each |
3,800 | |
| Filed 2024-01-05 09:20 Tx date 2023-12-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,900 vol |
0 | |
| Filed 2024-01-05 09:20 Tx date 2023-12-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,502
+3,900 vol $3.72 each |
3,900 | |
| Filed 2024-01-05 09:19 Tx date 2023-12-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,800 vol |
0 | |
| Filed 2024-01-05 09:18 Tx date 2023-12-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,388
+2,800 vol $3.71 each |
2,800 | |
| Filed 2024-01-05 09:18 Tx date 2023-12-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,500 vol |
0 | |
| Filed 2024-01-05 09:17 Tx date 2023-12-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,100
+2,500 vol $3.64 each |
2,500 | |
| Filed 2024-01-05 09:16 Tx date 2023-12-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2024-01-05 09:16 Tx date 2023-12-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,280
+2,000 vol $3.64 each |
2,000 | |
| Filed 2024-01-05 09:15 Tx date 2023-12-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-4,500 vol |
0 | |
| Filed 2024-01-05 09:15 Tx date 2023-12-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,074
+4,500 vol $3.57 each |
4,500 | |
| Filed 2024-01-05 09:14 Tx date 2023-12-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,700 vol |
0 | |
| Filed 2024-01-05 09:14 Tx date 2023-12-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,828
+2,700 vol $3.64 each |
2,700 | |
| Filed 2024-01-05 09:13 Tx date 2023-12-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,000 vol |
0 | |
| Filed 2024-01-05 09:12 Tx date 2023-12-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+5,000 vol $3.60 each |
5,000 | |
| Filed 2024-01-05 09:12 Tx date 2023-12-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,000 vol |
0 | |
| Filed 2024-01-05 09:11 Tx date 2023-12-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,125
+5,000 vol $3.63 each |
5,000 | |
| Filed 2024-01-05 09:10 Tx date 2023-12-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,400 vol |
0 | |
| Filed 2024-01-05 09:10 Tx date 2023-12-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,079
+3,400 vol $3.55 each |
3,400 | |
| Filed 2024-01-05 09:09 Tx date 2023-12-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2024-01-05 09:08 Tx date 2023-12-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,950
+5,300 vol $3.58 each |
5,300 | |
| Filed 2024-01-04 16:16 Tx date 2023-12-31 |
$HLS
HLS Therapeutics Inc. |
Roy, Christian
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$19,278
+5,060 vol $3.81 each |
5,060 | |
| Filed 2024-01-04 16:15 Tx date 2023-06-16 |
$HLS
HLS Therapeutics Inc. |
Roy, Christian
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-04 16:09 Tx date 2023-12-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$31,847
+8,359 vol $3.81 each |
66,271 | |
| Filed 2024-01-04 16:05 Tx date 2023-12-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$21,793
+5,720 vol $3.81 each |
60,865 | |
| Filed 2024-01-04 16:01 Tx date 2023-12-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,819
+1,265 vol $3.81 each |
39,113 | |
| Filed 2023-12-04 14:57 Tx date 2023-11-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-12-04 14:57 Tx date 2023-11-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,570
+1,000 vol $3.57 each |
1,000 | |
| Filed 2023-12-04 14:56 Tx date 2023-11-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,400 vol |
0 | |
| Filed 2023-12-04 14:56 Tx date 2023-11-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,783
+3,400 vol $3.47 each |
3,400 | |
| Filed 2023-12-04 14:55 Tx date 2023-11-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2023-12-04 14:55 Tx date 2023-11-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,200 vol |
0 | |
| Filed 2023-12-04 14:54 Tx date 2023-11-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,392
+5,300 vol $3.47 each |
5,300 | |
| Filed 2023-12-04 14:53 Tx date 2023-11-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,260
+1,200 vol $3.55 each |
1,200 | |
| Filed 2023-12-04 14:52 Tx date 2023-11-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2023-12-04 14:52 Tx date 2023-11-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$700.00
+200 vol $3.50 each |
200 | |
| Filed 2023-12-04 14:51 Tx date 2023-11-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,000 vol |
0 | |
| Filed 2023-12-04 14:51 Tx date 2023-11-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,125
+5,000 vol $3.63 each |
5,000 | |
| Filed 2023-12-04 14:50 Tx date 2023-11-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-12-04 14:50 Tx date 2023-11-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,000
+500 vol $4.00 each |
500 | |
| Filed 2023-12-04 14:49 Tx date 2023-11-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-12-04 14:48 Tx date 2023-11-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,480
+3,600 vol $4.30 each |
3,600 | |
| Filed 2023-12-04 14:48 Tx date 2023-11-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-12-04 14:47 Tx date 2023-11-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,280
+3,600 vol $4.80 each |
3,600 | |
| Filed 2023-12-04 14:47 Tx date 2023-11-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-12-04 14:46 Tx date 2023-11-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,460
+3,600 vol $4.85 each |
3,600 | |
| Filed 2023-12-04 14:45 Tx date 2023-11-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-12-04 14:45 Tx date 2023-11-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,460
+3,600 vol $4.85 each |
3,600 | |
| Filed 2023-12-04 14:44 Tx date 2023-11-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2023-12-04 14:44 Tx date 2023-11-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$976.00
+200 vol $4.88 each |
200 | |
| Filed 2023-12-04 14:41 Tx date 2023-11-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-12-04 14:41 Tx date 2023-11-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-12-04 14:40 Tx date 2023-11-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-12-04 14:40 Tx date 2023-11-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,748
+3,600 vol $4.93 each |
3,600 | |
| Filed 2023-12-04 14:39 Tx date 2023-11-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2023-12-04 14:38 Tx date 2023-11-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$986.00
+200 vol $4.93 each |
200 | |
| Filed 2023-11-27 08:52 Tx date 2023-11-08 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-18,000 vol |
47,131 | |
| Filed 2023-11-27 08:51 Tx date 2023-11-08 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-20,000 vol |
110,992 | |
| Filed 2023-11-27 08:48 Tx date 2023-11-08 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-18,000 vol |
9,720 | |
| Filed 2023-11-17 14:15 Tx date 2023-11-16 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,000
+5,000 vol $2.60 each |
10,000 | |
| Filed 2023-11-15 14:58 Tx date 2023-11-15 |
$HLS
HLS Therapeutics Inc. |
Walsh, Brian Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,910
+1,000 vol $2.91 each |
1,200 | |
| Filed 2023-11-15 14:58 Tx date 2023-11-13 |
$HLS
HLS Therapeutics Inc. |
Walsh, Brian Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$584.00
+200 vol $2.92 each |
200 | |
| Filed 2023-11-15 14:57 Tx date 2023-06-27 |
$HLS
HLS Therapeutics Inc. |
Walsh, Brian Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-14 16:18 Tx date 2023-11-10 |
$HLS
HLS Therapeutics Inc. |
Polar Asset Management Partners Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$86,000
+20,000 vol $4.30 each |
6,367,082 | |
| Filed 2023-11-14 16:17 Tx date 2023-11-10 |
$HLS
HLS Therapeutics Inc. |
Polar Asset Management Partners Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,876
+2,400 vol $3.70 each |
6,347,082 | |
| Filed 2023-11-14 16:17 Tx date 2023-11-09 |
$HLS
HLS Therapeutics Inc. |
Polar Asset Management Partners Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,600
+10,000 vol $4.36 each |
6,344,682 | |
| Filed 2023-11-08 16:01 Tx date 2023-11-03 |
$HLS
HLS Therapeutics Inc. |
Polar Asset Management Partners Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,334,682 | ||
| Filed 2023-11-02 15:28 Tx date 2023-10-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-24,300 vol |
0 | |
| Filed 2023-11-02 15:27 Tx date 2023-10-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$119,799
+24,300 vol $4.93 each |
24,300 | |
| Filed 2023-11-02 15:26 Tx date 2023-10-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:26 Tx date 2023-10-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-11-02 15:25 Tx date 2023-10-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2023-11-02 15:24 Tx date 2023-10-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
-3,600 | |
| Filed 2023-11-02 15:24 Tx date 2023-10-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$473.00
+100 vol $4.73 each |
100 | |
| Filed 2023-11-02 15:23 Tx date 2023-10-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
0 | |
| Filed 2023-11-02 15:23 Tx date 2023-10-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:22 Tx date 2023-10-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,822
+3,600 vol $4.95 each |
3,600 | |
| Filed 2023-11-02 15:22 Tx date 2023-10-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:21 Tx date 2023-10-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,039
+3,600 vol $5.01 each |
3,600 | |
| Filed 2023-11-02 15:20 Tx date 2023-10-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:20 Tx date 2023-10-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,928
+3,600 vol $4.98 each |
3,600 | |
| Filed 2023-11-02 15:19 Tx date 2023-10-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:19 Tx date 2023-10-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,972
+3,600 vol $5.27 each |
3,600 | |
| Filed 2023-11-02 15:18 Tx date 2023-10-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:18 Tx date 2023-10-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,985
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-11-02 15:17 Tx date 2023-10-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,300 vol |
0 | |
| Filed 2023-11-02 15:17 Tx date 2023-10-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,500
+1,300 vol $5.00 each |
1,300 | |
| Filed 2023-11-02 15:16 Tx date 2023-10-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2023-11-02 15:16 Tx date 2023-10-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$980.00
+200 vol $4.90 each |
200 | |
| Filed 2023-11-02 15:15 Tx date 2023-10-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:15 Tx date 2023-10-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-11-02 15:14 Tx date 2023-10-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:14 Tx date 2023-10-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-11-02 15:13 Tx date 2023-10-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:13 Tx date 2023-10-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,892
+3,600 vol $4.97 each |
3,600 | |
| Filed 2023-11-02 15:12 Tx date 2023-10-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-600 vol |
0 | |
| Filed 2023-11-02 15:12 Tx date 2023-10-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,956
+600 vol $4.93 each |
600 | |
| Filed 2023-11-02 15:11 Tx date 2023-10-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:11 Tx date 2023-10-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,928
+3,600 vol $4.98 each |
3,600 | |
| Filed 2023-11-02 15:10 Tx date 2023-10-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:10 Tx date 2023-10-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,820
+3,600 vol $4.95 each |
3,600 | |
| Filed 2023-11-02 15:09 Tx date 2023-10-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:09 Tx date 2023-10-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,856
+3,600 vol $4.96 each |
3,600 | |
| Filed 2023-11-02 15:08 Tx date 2023-10-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-11-02 15:08 Tx date 2023-10-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,892
+3,600 vol $4.97 each |
3,600 | |
| Filed 2023-11-02 15:07 Tx date 2023-10-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,200 vol |
0 | |
| Filed 2023-11-02 15:06 Tx date 2023-10-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,124
+2,200 vol $5.06 each |
2,200 | |
| Filed 2023-10-05 15:06 Tx date 2023-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$31,887
+6,228 vol $5.12 each |
57,912 | |
| Filed 2023-10-05 15:04 Tx date 2023-09-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$21,816
+4,261 vol $5.12 each |
55,145 | |
| Filed 2023-10-05 15:02 Tx date 2023-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,823
+942 vol $5.12 each |
37,848 | |
| Filed 2023-10-03 15:06 Tx date 2023-09-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,100 vol |
0 | |
| Filed 2023-10-03 15:05 Tx date 2023-09-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,498
+2,100 vol $5.00 each |
2,100 | |
| Filed 2023-10-03 15:05 Tx date 2023-09-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-10-03 15:04 Tx date 2023-09-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,320
+3,600 vol $5.09 each |
3,600 | |
| Filed 2023-10-03 15:04 Tx date 2023-09-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2023-10-03 15:03 Tx date 2023-09-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,030
+200 vol $5.15 each |
200 | |
| Filed 2023-10-03 15:03 Tx date 2023-09-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-10-03 15:02 Tx date 2023-09-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,900
+3,600 vol $5.25 each |
3,600 | |
| Filed 2023-10-03 15:00 Tx date 2023-09-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-10-03 15:00 Tx date 2023-09-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,708
+3,600 vol $5.20 each |
3,600 | |
| Filed 2023-10-03 14:59 Tx date 2023-09-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-10-03 14:59 Tx date 2023-09-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,720
+3,600 vol $5.20 each |
3,600 | |
| Filed 2023-10-03 14:58 Tx date 2023-09-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-10-03 14:58 Tx date 2023-09-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,900
+1,000 vol $4.90 each |
1,000 | |
| Filed 2023-10-03 14:57 Tx date 2023-09-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-10-03 14:57 Tx date 2023-09-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-10-03 14:56 Tx date 2023-09-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-10-03 14:56 Tx date 2023-09-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-10-03 14:55 Tx date 2023-09-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-10-03 14:55 Tx date 2023-09-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-10-03 14:54 Tx date 2023-09-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-10-03 14:54 Tx date 2023-09-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,648
+3,600 vol $5.18 each |
3,600 | |
| Filed 2023-10-03 14:53 Tx date 2023-09-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-10-03 14:53 Tx date 2023-09-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,856
+3,600 vol $4.96 each |
3,600 | |
| Filed 2023-10-03 14:52 Tx date 2023-09-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,100 vol |
0 | |
| Filed 2023-10-03 14:52 Tx date 2023-09-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,137
+1,100 vol $4.67 each |
1,100 | |
| Filed 2023-10-03 14:51 Tx date 2023-09-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-400 vol |
0 | |
| Filed 2023-10-03 14:51 Tx date 2023-09-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,832
+400 vol $4.58 each |
400 | |
| Filed 2023-09-05 15:32 Tx date 2023-08-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,100 vol |
0 | |
| Filed 2023-09-05 15:31 Tx date 2023-08-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:30 Tx date 2023-08-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,049
+1,100 vol $4.59 each |
1,100 | |
| Filed 2023-09-05 15:29 Tx date 2023-08-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,399
+3,600 vol $4.56 each |
3,600 | |
| Filed 2023-09-05 15:29 Tx date 2023-08-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:28 Tx date 2023-08-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,815
+3,600 vol $4.39 each |
3,600 | |
| Filed 2023-09-05 15:27 Tx date 2023-08-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:27 Tx date 2023-08-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,099
+3,600 vol $4.47 each |
3,600 | |
| Filed 2023-09-05 15:26 Tx date 2023-08-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:25 Tx date 2023-08-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,200
+3,600 vol $4.50 each |
3,600 | |
| Filed 2023-09-05 15:25 Tx date 2023-08-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2023-09-05 15:24 Tx date 2023-08-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$870.00
+200 vol $4.35 each |
200 | |
| Filed 2023-09-05 15:24 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-09-05 15:23 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,380
+500 vol $4.76 each |
500 | |
| Filed 2023-09-05 15:23 Tx date 2023-08-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,500 vol |
0 | |
| Filed 2023-09-05 15:22 Tx date 2023-08-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,149
+1,500 vol $4.77 each |
1,500 | |
| Filed 2023-09-05 15:21 Tx date 2023-08-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:20 Tx date 2023-08-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-09-05 15:20 Tx date 2023-08-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:19 Tx date 2023-08-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,958
+3,600 vol $4.99 each |
3,600 | |
| Filed 2023-09-05 15:19 Tx date 2023-08-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:18 Tx date 2023-08-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,892
+3,600 vol $4.97 each |
3,600 | |
| Filed 2023-09-05 15:18 Tx date 2023-08-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:17 Tx date 2023-08-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,928
+3,600 vol $4.98 each |
3,600 | |
| Filed 2023-09-05 15:14 Tx date 2023-08-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:14 Tx date 2023-08-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,000
+3,600 vol $5.00 each |
3,600 | |
| Filed 2023-09-05 15:13 Tx date 2023-08-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:13 Tx date 2023-08-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,698
+3,600 vol $5.19 each |
3,600 | |
| Filed 2023-09-05 15:12 Tx date 2023-08-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:11 Tx date 2023-08-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,247
+3,600 vol $5.35 each |
3,600 | |
| Filed 2023-09-05 15:10 Tx date 2023-08-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:10 Tx date 2023-08-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,240
+3,600 vol $5.90 each |
3,600 | |
| Filed 2023-09-05 15:09 Tx date 2023-08-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,100 vol |
0 | |
| Filed 2023-09-05 15:09 Tx date 2023-08-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,290
+3,100 vol $5.90 each |
3,100 | |
| Filed 2023-09-05 15:08 Tx date 2023-08-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:08 Tx date 2023-08-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,594
+3,600 vol $6.00 each |
3,600 | |
| Filed 2023-09-05 15:07 Tx date 2023-08-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:06 Tx date 2023-08-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,417
+3,600 vol $6.23 each |
3,600 | |
| Filed 2023-09-05 15:05 Tx date 2023-08-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-09-05 15:05 Tx date 2023-08-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,597
+3,600 vol $6.00 each |
3,600 | |
| Filed 2023-08-29 14:51 Tx date 2023-08-25 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,000
+4,000 vol $4.50 each |
4,000 | |
| Filed 2023-08-29 14:49 Tx date 2023-06-21 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-23 13:02 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,000
+20,000 vol $4.70 each |
40,384 | |
| Filed 2023-08-23 13:00 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,000
+20,000 vol $4.70 each |
39,390 | |
| Filed 2023-08-23 12:58 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,000
+20,000 vol $4.70 each |
54,105 | |
| Filed 2023-08-23 12:57 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$164,500
+35,000 vol $4.70 each |
166,729 | |
| Filed 2023-08-23 12:55 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Walsh, Brian Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$352,500
+75,000 vol $4.70 each |
75,000 | |
| Filed 2023-08-23 12:54 Tx date 2023-06-27 |
$HLS
HLS Therapeutics Inc. |
Walsh, Brian Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-23 12:53 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$352,500
+75,000 vol $4.70 each |
145,454 | |
| Filed 2023-08-23 12:50 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$470,000
+100,000 vol $4.70 each |
242,294 | |
| Filed 2023-08-04 14:27 Tx date 2023-07-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:27 Tx date 2023-07-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,284
+3,600 vol $6.19 each |
3,600 | |
| Filed 2023-08-04 14:26 Tx date 2023-07-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:26 Tx date 2023-07-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,068
+3,600 vol $6.13 each |
3,600 | |
| Filed 2023-08-04 14:25 Tx date 2023-07-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:25 Tx date 2023-07-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,680
+3,600 vol $6.30 each |
3,600 | |
| Filed 2023-08-04 14:25 Tx date 2023-07-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:24 Tx date 2023-07-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,680
+3,600 vol $6.30 each |
3,600 | |
| Filed 2023-08-04 14:24 Tx date 2023-07-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:23 Tx date 2023-07-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,040
+3,600 vol $6.40 each |
3,600 | |
| Filed 2023-08-04 14:23 Tx date 2023-07-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:22 Tx date 2023-07-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,176
+3,600 vol $6.16 each |
3,600 | |
| Filed 2023-08-04 14:22 Tx date 2023-07-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:21 Tx date 2023-07-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,464
+3,600 vol $6.24 each |
3,600 | |
| Filed 2023-08-04 14:20 Tx date 2023-07-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:19 Tx date 2023-07-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,364
+3,600 vol $6.49 each |
3,600 | |
| Filed 2023-08-04 14:19 Tx date 2023-07-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:18 Tx date 2023-07-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,228
+3,600 vol $6.73 each |
3,600 | |
| Filed 2023-08-04 14:18 Tx date 2023-07-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:17 Tx date 2023-07-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,624
+3,600 vol $6.84 each |
3,600 | |
| Filed 2023-08-04 14:17 Tx date 2023-07-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:16 Tx date 2023-07-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,200
+3,600 vol $7.00 each |
3,600 | |
| Filed 2023-08-04 14:16 Tx date 2023-07-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-300 vol |
0 | |
| Filed 2023-08-04 14:15 Tx date 2023-07-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,010
+300 vol $6.70 each |
300 | |
| Filed 2023-08-04 14:14 Tx date 2023-07-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:14 Tx date 2023-07-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,588
+3,600 vol $6.83 each |
3,600 | |
| Filed 2023-08-04 14:13 Tx date 2023-07-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-08-04 14:12 Tx date 2023-07-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,600
+1,000 vol $6.60 each |
1,000 | |
| Filed 2023-08-04 14:12 Tx date 2023-07-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-08-04 14:11 Tx date 2023-07-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,210
+1,000 vol $6.21 each |
1,000 | |
| Filed 2023-08-04 14:10 Tx date 2023-07-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,700 vol |
0 | |
| Filed 2023-08-04 14:10 Tx date 2023-07-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,421
+1,700 vol $6.13 each |
1,700 | |
| Filed 2023-08-04 14:09 Tx date 2023-07-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-08-04 14:09 Tx date 2023-07-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,860
+3,600 vol $6.35 each |
3,600 | |
| Filed 2023-08-04 14:08 Tx date 2023-07-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-900 vol |
0 | |
| Filed 2023-08-04 14:08 Tx date 2023-07-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,400
+900 vol $6.00 each |
900 | |
| Filed 2023-07-05 15:38 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$34,983
+6,063 vol $5.77 each |
51,684 | |
| Filed 2023-07-05 15:36 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$33,385
+5,786 vol $5.77 each |
50,884 | |
| Filed 2023-07-05 15:34 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,858
+842 vol $5.77 each |
36,906 | |
| Filed 2023-07-04 15:36 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-07-04 15:36 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,032
+3,600 vol $6.12 each |
3,600 | |
| Filed 2023-07-04 15:35 Tx date 2023-06-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-870 vol |
0 | |
| Filed 2023-07-04 15:35 Tx date 2023-06-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,350
+870 vol $6.15 each |
870 | |
| Filed 2023-07-04 15:34 Tx date 2023-06-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-07-04 15:34 Tx date 2023-06-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,472
+3,600 vol $6.52 each |
3,600 | |
| Filed 2023-07-04 15:33 Tx date 2023-06-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-300 vol |
0 | |
| Filed 2023-07-04 15:33 Tx date 2023-06-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,869
+300 vol $6.23 each |
300 | |
| Filed 2023-07-04 15:32 Tx date 2023-06-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-07-04 15:32 Tx date 2023-06-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,200
+1,000 vol $6.20 each |
1,000 | |
| Filed 2023-07-04 15:31 Tx date 2023-06-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,000 vol |
0 | |
| Filed 2023-07-04 15:31 Tx date 2023-06-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,810
+3,000 vol $6.27 each |
3,000 | |
| Filed 2023-07-04 15:30 Tx date 2023-06-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-07-04 15:30 Tx date 2023-06-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,256
+3,600 vol $6.46 each |
3,600 | |
| Filed 2023-07-04 15:29 Tx date 2023-06-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2023-07-04 15:29 Tx date 2023-06-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,200
+2,000 vol $6.60 each |
2,000 | |
| Filed 2023-07-04 15:28 Tx date 2023-06-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-700 vol |
0 | |
| Filed 2023-07-04 15:28 Tx date 2023-06-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,109
+700 vol $5.87 each |
700 | |
| Filed 2023-07-04 15:27 Tx date 2023-06-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,700 vol |
0 | |
| Filed 2023-07-04 15:27 Tx date 2023-06-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,132
+1,700 vol $5.96 each |
1,700 | |
| Filed 2023-07-04 15:26 Tx date 2023-06-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-07-04 15:26 Tx date 2023-06-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,985
+500 vol $5.97 each |
500 | |
| Filed 2023-07-04 15:25 Tx date 2023-06-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2023-07-04 15:25 Tx date 2023-06-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$998.00
+200 vol $4.99 each |
200 | |
| Filed 2023-07-04 15:24 Tx date 2023-06-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-07-04 15:23 Tx date 2023-06-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,480
+3,600 vol $4.30 each |
3,600 | |
| Filed 2023-07-04 15:23 Tx date 2023-06-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-07-04 15:22 Tx date 2023-06-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,125
+500 vol $4.25 each |
500 | |
| Filed 2023-07-04 15:22 Tx date 2023-06-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2023-07-04 15:21 Tx date 2023-06-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,600
+2,000 vol $4.30 each |
2,000 | |
| Filed 2023-07-04 15:21 Tx date 2023-06-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-07-04 15:20 Tx date 2023-06-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,552
+3,600 vol $4.32 each |
3,600 | |
| Filed 2023-07-04 15:19 Tx date 2023-06-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-07-04 15:19 Tx date 2023-06-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,588
+3,600 vol $4.33 each |
3,600 | |
| Filed 2023-07-04 12:18 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,507,500
-1,300,000 vol $5.78 each |
3,051,782 | |
| Filed 2023-06-12 15:51 Tx date 2023-06-08 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$417,100
+97,000 vol $4.30 each |
97,000 | |
| Filed 2023-06-12 15:49 Tx date 2021-06-18 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-05 10:13 Tx date 2023-05-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2023-06-05 10:12 Tx date 2023-05-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,440
+2,000 vol $4.22 each |
2,000 | |
| Filed 2023-06-05 10:11 Tx date 2023-05-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-06-05 10:09 Tx date 2023-05-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,220
+3,600 vol $4.23 each |
3,600 | |
| Filed 2023-06-05 10:08 Tx date 2023-05-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-06-05 10:08 Tx date 2023-05-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,120
+500 vol $4.24 each |
500 | |
| Filed 2023-06-05 10:07 Tx date 2023-05-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-06-05 10:07 Tx date 2023-05-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,220
+3,600 vol $4.23 each |
3,600 | |
| Filed 2023-06-05 10:06 Tx date 2023-05-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,699 vol |
0 | |
| Filed 2023-06-05 10:06 Tx date 2023-05-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,641
+3,699 vol $4.23 each |
3,699 | |
| Filed 2023-06-05 10:04 Tx date 2023-05-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-06-05 10:03 Tx date 2023-05-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,950
+3,600 vol $4.43 each |
3,600 | |
| Filed 2023-06-05 10:03 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,500 vol |
0 | |
| Filed 2023-06-05 10:02 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,750
+1,500 vol $4.50 each |
1,500 | |
| Filed 2023-05-29 14:09 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,996
+900 vol $4.44 each |
57,500 | |
| Filed 2023-05-19 13:21 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,986
+900 vol $4.43 each |
||
| Filed 2023-05-23 09:01 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+2,500 vol $4.50 each |
67,500 | |
| Filed 2023-05-23 09:01 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,576
+800 vol $4.47 each |
65,000 | |
| Filed 2023-05-23 09:00 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,589
+3,900 vol $4.51 each |
64,200 | |
| Filed 2023-05-23 08:59 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,600
+2,800 vol $4.50 each |
60,300 | |
| Filed 2023-05-19 13:21 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,986
+900 vol $4.43 each |
57,500 | |
| Filed 2023-05-19 13:21 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+2,500 vol $4.50 each |
56,600 | |
| Filed 2023-05-19 13:20 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,398
+4,700 vol $4.34 each |
54,100 | |
| Filed 2023-05-19 13:19 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,530
+1,700 vol $4.43 each |
49,400 | |
| Filed 2023-05-19 13:18 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$884.00
+200 vol $4.42 each |
47,700 | |
| Filed 2023-05-19 13:11 Tx date 2023-05-16 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,742,000
+600,000 vol $4.57 each |
600,000 | |
| Filed 2023-05-19 13:11 Tx date 2023-05-01 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-19 13:10 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,800
+2,000 vol $3.40 each |
5,000 | |
| Filed 2023-05-15 13:58 Tx date 2023-05-15 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,158
+3,000 vol $3.39 each |
3,000 | |
| Filed 2023-05-15 13:57 Tx date 2023-05-01 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-04 16:29 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$20,363
+3,322 vol $6.13 each |
45,621 | |
| Filed 2023-04-04 16:27 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$11,027
+1,799 vol $6.13 each |
39,860 | |
| Filed 2023-04-04 16:25 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$19,517
+3,184 vol $6.13 each |
45,098 | |
| Filed 2023-04-04 16:24 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,879
+796 vol $6.13 each |
36,064 | |
| Filed 2023-04-04 16:20 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$27,149
+4,429 vol $6.13 each |
54,649 | |
| Filed 2023-03-03 13:33 Tx date 2023-02-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-03-03 13:33 Tx date 2023-02-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,364
+500 vol $8.73 each |
500 | |
| Filed 2023-03-03 13:32 Tx date 2023-02-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,300 vol |
0 | |
| Filed 2023-03-03 13:32 Tx date 2023-02-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,326
+1,300 vol $8.71 each |
1,300 | |
| Filed 2023-03-03 13:31 Tx date 2023-02-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2023-03-03 13:31 Tx date 2023-02-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,730
+200 vol $8.65 each |
200 | |
| Filed 2023-03-03 13:30 Tx date 2023-02-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,100 vol |
0 | |
| Filed 2023-03-03 13:30 Tx date 2023-02-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,520
+1,100 vol $8.65 each |
1,100 | |
| Filed 2023-03-03 13:29 Tx date 2023-02-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,200 vol |
0 | |
| Filed 2023-03-03 13:29 Tx date 2023-02-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,527
+1,200 vol $8.77 each |
1,200 | |
| Filed 2023-03-03 13:28 Tx date 2023-02-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-03-03 13:28 Tx date 2023-02-10 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,800
+1,000 vol $8.80 each |
1,000 | |
| Filed 2023-03-03 13:28 Tx date 2023-02-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,400 vol |
0 | |
| Filed 2023-03-03 13:27 Tx date 2023-02-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,319
+2,400 vol $8.88 each |
2,400 | |
| Filed 2023-03-03 13:26 Tx date 2023-02-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-03-03 13:26 Tx date 2023-02-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,920
+1,000 vol $8.92 each |
1,000 | |
| Filed 2023-03-03 13:25 Tx date 2023-02-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,600 vol |
0 | |
| Filed 2023-03-03 13:25 Tx date 2023-02-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$32,519
+3,600 vol $9.03 each |
3,600 | |
| Filed 2023-03-03 13:24 Tx date 2023-02-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2023-03-03 13:24 Tx date 2023-02-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,700
+2,000 vol $9.35 each |
2,000 | |
| Filed 2023-03-03 13:23 Tx date 2023-02-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2023-03-03 13:23 Tx date 2023-02-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,600
+2,000 vol $9.30 each |
2,000 | |
| Filed 2023-02-03 15:17 Tx date 2023-01-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-02-03 15:16 Tx date 2023-01-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,400
+1,000 vol $9.40 each |
1,000 | |
| Filed 2023-02-03 15:16 Tx date 2023-01-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-02-03 15:16 Tx date 2023-01-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,600
+1,000 vol $9.60 each |
1,000 | |
| Filed 2023-02-03 15:15 Tx date 2023-01-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,400 vol |
0 | |
| Filed 2023-02-03 15:14 Tx date 2023-01-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,440
+1,400 vol $9.60 each |
1,400 | |
| Filed 2023-02-03 15:14 Tx date 2023-01-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2023-02-03 15:13 Tx date 2023-01-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,500
+2,000 vol $9.75 each |
2,000 | |
| Filed 2023-02-03 15:12 Tx date 2023-01-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-02-03 15:12 Tx date 2023-01-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,850
+500 vol $9.70 each |
500 | |
| Filed 2023-02-03 15:11 Tx date 2023-01-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,100 vol |
0 | |
| Filed 2023-02-03 15:11 Tx date 2023-01-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,900
+2,100 vol $9.95 each |
2,100 | |
| Filed 2023-02-03 15:10 Tx date 2023-01-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-02-03 15:10 Tx date 2023-01-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,100
+500 vol $10.20 each |
500 | |
| Filed 2023-02-03 15:09 Tx date 2023-01-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-02-03 15:09 Tx date 2023-01-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,100
+500 vol $10.20 each |
500 | |
| Filed 2023-02-03 15:08 Tx date 2023-01-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2023-02-03 15:08 Tx date 2023-01-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$990.00
+100 vol $9.90 each |
100 | |
| Filed 2023-02-03 15:04 Tx date 2023-01-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-02-03 15:03 Tx date 2023-01-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,850
+500 vol $9.70 each |
500 | |
| Filed 2023-02-03 15:03 Tx date 2023-01-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-700 vol |
0 | |
| Filed 2023-02-03 15:02 Tx date 2023-01-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,814
+700 vol $9.74 each |
700 | |
| Filed 2023-02-03 15:02 Tx date 2023-01-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2023-02-03 15:01 Tx date 2023-01-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$981.00
+100 vol $9.81 each |
100 | |
| Filed 2023-01-04 16:14 Tx date 2022-12-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2023-01-04 16:13 Tx date 2022-12-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,910
+1,000 vol $9.91 each |
1,000 | |
| Filed 2023-01-04 16:13 Tx date 2022-12-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-01-04 16:12 Tx date 2022-12-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,000
+500 vol $10.00 each |
500 | |
| Filed 2023-01-04 16:12 Tx date 2022-12-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2023-01-04 16:11 Tx date 2022-12-01 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,955
+500 vol $9.91 each |
500 | |
| Filed 2023-01-04 15:29 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$19,578
+2,048 vol $9.56 each |
42,299 | |
| Filed 2023-01-04 15:27 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$10,602
+1,109 vol $9.56 each |
38,061 | |
| Filed 2023-01-04 15:25 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,756
+1,962 vol $9.56 each |
41,914 | |
| Filed 2023-01-04 15:23 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,684
+490 vol $9.56 each |
35,268 | |
| Filed 2023-01-04 15:21 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$26,098
+2,730 vol $9.56 each |
50,220 | |
| Filed 2023-01-03 09:03 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,351
+2,062 vol $8.90 each |
19,770 | |
| Filed 2022-10-05 16:03 Tx date 2022-09-02 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,351
+2,062 vol $8.90 each |
||
| Filed 2022-12-16 16:16 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
34,778 | |
| Filed 2022-12-16 16:14 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
36,952 | |
| Filed 2022-12-16 16:12 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
33,053 | |
| Filed 2022-12-16 16:09 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$220,660
+21,826 vol $10.11 each |
34,697 | |
| Filed 2022-12-16 16:07 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,450
+1,825 vol $10.11 each |
1,825 | |
| Filed 2022-12-16 16:06 Tx date 2022-11-28 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-16 16:04 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
33,053 | |
| Filed 2022-12-16 16:01 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
40,251 | |
| Filed 2022-12-16 15:59 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
39,952 | |
| Filed 2022-12-16 15:56 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$231,235
+22,872 vol $10.11 each |
47,490 | |
| Filed 2022-12-16 09:38 Tx date 2022-06-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
1,583 | ||
| Filed 2022-12-15 15:25 Tx date 2022-06-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-15 15:33 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$24,170
+2,417 vol $10.00 each |
9,730 | |
| Filed 2022-12-15 15:32 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,912
+4,902 vol $10.59 each |
20,384 | |
| Filed 2022-12-15 15:29 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$49,730
+4,973 vol $10.00 each |
27,720 | |
| Filed 2022-12-15 15:28 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$106,810
+10,086 vol $10.59 each |
131,729 | |
| Filed 2022-12-15 15:26 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$31,670
+3,167 vol $10.00 each |
7,250 | |
| Filed 2022-12-15 15:25 Tx date 2022-06-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
4,083 | ||
| Filed 2022-12-15 15:20 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$68,019
+6,423 vol $10.59 each |
19,390 | |
| Filed 2022-12-15 15:17 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$31,250
+3,125 vol $10.00 each |
17,925 | |
| Filed 2022-12-15 15:16 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$67,130
+6,339 vol $10.59 each |
34,105 | |
| Filed 2022-12-15 15:13 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$321,250
+32,125 vol $10.00 each |
65,131 | |
| Filed 2022-12-15 15:10 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$884,320
+88,432 vol $10.00 each |
147,198 | |
| Filed 2022-12-15 15:08 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$788,720
+78,872 vol $10.00 each |
130,992 | |
| Filed 2022-12-15 15:04 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$3,277,790
+327,779 vol $10.00 each |
527,020 | |
| Filed 2022-12-05 13:02 Tx date 2022-11-28 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,765 | ||
| Filed 2022-12-02 16:27 Tx date 2022-11-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-12-02 16:27 Tx date 2022-11-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,805
+2,000 vol $9.40 each |
2,000 | |
| Filed 2022-12-02 16:26 Tx date 2022-11-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-12-02 16:26 Tx date 2022-11-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,400
+2,000 vol $9.70 each |
2,000 | |
| Filed 2022-12-02 16:25 Tx date 2022-11-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,500 vol |
0 | |
| Filed 2022-12-02 16:24 Tx date 2022-11-28 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,102
+3,500 vol $9.74 each |
3,500 | |
| Filed 2022-12-02 16:23 Tx date 2022-11-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,700 vol |
0 | |
| Filed 2022-12-02 16:22 Tx date 2022-11-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,873
+1,700 vol $8.75 each |
1,700 | |
| Filed 2022-12-02 16:22 Tx date 2022-11-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,500 vol |
0 | |
| Filed 2022-12-02 16:21 Tx date 2022-11-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,236
+2,500 vol $8.49 each |
2,500 | |
| Filed 2022-12-02 16:20 Tx date 2022-11-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,000 vol |
0 | |
| Filed 2022-12-02 16:20 Tx date 2022-11-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,400
+3,000 vol $8.47 each |
3,000 | |
| Filed 2022-12-02 16:19 Tx date 2022-11-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,000 vol |
0 | |
| Filed 2022-12-02 16:18 Tx date 2022-11-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,290
+3,000 vol $8.43 each |
3,000 | |
| Filed 2022-12-02 16:17 Tx date 2022-11-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,200 vol |
0 | |
| Filed 2022-12-02 16:17 Tx date 2022-11-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,233
+2,200 vol $10.11 each |
2,200 | |
| Filed 2022-12-02 16:16 Tx date 2022-11-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-12-02 16:15 Tx date 2022-11-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,980
+2,000 vol $9.99 each |
2,000 | |
| Filed 2022-12-02 16:15 Tx date 2022-11-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-12-02 16:13 Tx date 2022-11-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,000
+1,000 vol $10.00 each |
1,000 | |
| Filed 2022-12-02 16:12 Tx date 2022-11-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-12-02 16:11 Tx date 2022-11-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,150
+2,000 vol $10.07 each |
2,000 | |
| Filed 2022-11-03 11:39 Tx date 2022-10-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-11-03 11:39 Tx date 2022-10-31 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,870
+1,000 vol $9.87 each |
1,000 | |
| Filed 2022-11-03 11:19 Tx date 2022-10-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-700 vol |
0 | |
| Filed 2022-11-03 11:18 Tx date 2022-10-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,300
+700 vol $9.00 each |
700 | |
| Filed 2022-11-03 11:17 Tx date 2022-10-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,000 vol |
0 | |
| Filed 2022-11-03 11:17 Tx date 2022-10-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,000
+1,000 vol $9.00 each |
1,000 | |
| Filed 2022-11-03 11:16 Tx date 2022-10-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-400 vol |
0 | |
| Filed 2022-11-03 11:16 Tx date 2022-10-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,600
+400 vol $9.00 each |
400 | |
| Filed 2022-11-03 11:15 Tx date 2022-10-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2022-11-03 11:15 Tx date 2022-10-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,500
+500 vol $9.00 each |
500 | |
| Filed 2022-11-03 11:14 Tx date 2022-10-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-700 vol |
0 | |
| Filed 2022-11-03 11:14 Tx date 2022-10-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,300
+700 vol $9.00 each |
700 | |
| Filed 2022-11-03 11:04 Tx date 2022-10-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-11-03 11:03 Tx date 2022-10-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,100
+2,000 vol $9.05 each |
2,000 | |
| Filed 2022-11-03 11:03 Tx date 2022-10-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-600 vol |
0 | |
| Filed 2022-11-03 11:02 Tx date 2022-10-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,348
+600 vol $8.91 each |
600 | |
| Filed 2022-11-03 11:02 Tx date 2022-10-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,000 vol |
0 | |
| Filed 2022-11-03 11:01 Tx date 2022-10-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$26,700
+3,000 vol $8.90 each |
3,000 | |
| Filed 2022-11-03 11:01 Tx date 2022-10-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-11-03 11:00 Tx date 2022-10-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,910
+2,000 vol $8.96 each |
2,000 | |
| Filed 2022-11-03 11:00 Tx date 2022-10-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-11-03 10:59 Tx date 2022-10-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,982
+2,000 vol $8.99 each |
2,000 | |
| Filed 2022-11-03 10:59 Tx date 2022-10-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-11-03 10:58 Tx date 2022-10-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,900
+2,000 vol $8.95 each |
2,000 | |
| Filed 2022-11-03 10:57 Tx date 2022-10-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2022-11-03 10:56 Tx date 2022-10-07 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$904.00
+100 vol $9.04 each |
100 | |
| Filed 2022-11-03 10:56 Tx date 2022-10-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-11-03 10:55 Tx date 2022-10-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,000
+1,000 vol $9.00 each |
1,000 | |
| Filed 2022-11-03 10:55 Tx date 2022-10-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-11-03 10:54 Tx date 2022-10-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,150
+2,000 vol $9.07 each |
2,000 | |
| Filed 2022-11-03 10:54 Tx date 2022-10-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,800 vol |
0 | |
| Filed 2022-11-03 10:53 Tx date 2022-10-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,954
+1,800 vol $9.42 each |
1,800 | |
| Filed 2022-11-03 10:52 Tx date 2022-10-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-11-03 10:52 Tx date 2022-10-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,700
+2,000 vol $9.35 each |
2,000 | |
| Filed 2022-10-05 16:06 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$19,143
+2,151 vol $8.90 each |
20,069 | |
| Filed 2022-10-05 16:04 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$10,368
+1,165 vol $8.90 each |
16,770 | |
| Filed 2022-10-05 16:03 Tx date 2022-09-02 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,351
+2,062 vol $8.90 each |
19,770 | |
| Filed 2022-10-05 16:01 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,583
+515 vol $8.90 each |
14,596 | |
| Filed 2022-10-05 15:57 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$25,534
+2,869 vol $8.90 each |
24,618 | |
| Filed 2022-10-04 15:44 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-10-04 15:43 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,300
+2,000 vol $9.15 each |
2,000 | |
| Filed 2022-09-01 20:36 Tx date 2022-08-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,900 vol |
0 | |
| Filed 2022-09-01 20:35 Tx date 2022-08-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$48,169
+3,900 vol $12.35 each |
3,900 | |
| Filed 2022-09-01 20:35 Tx date 2022-08-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-09-01 20:34 Tx date 2022-08-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,060
+2,000 vol $12.53 each |
2,000 | |
| Filed 2022-09-01 20:34 Tx date 2022-08-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2022-09-01 20:34 Tx date 2022-08-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,280
+100 vol $12.80 each |
100 | |
| Filed 2022-09-01 20:33 Tx date 2022-08-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-900 vol |
0 | |
| Filed 2022-09-01 20:33 Tx date 2022-08-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,520
+900 vol $12.80 each |
900 | |
| Filed 2022-09-01 20:33 Tx date 2022-08-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2022-09-01 20:32 Tx date 2022-08-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,270
+100 vol $12.70 each |
100 | |
| Filed 2022-09-01 20:32 Tx date 2022-08-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2022-09-01 20:32 Tx date 2022-08-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,283
+100 vol $12.83 each |
100 | |
| Filed 2022-09-01 20:31 Tx date 2022-08-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2022-09-01 20:31 Tx date 2022-08-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,575
+200 vol $12.88 each |
200 | |
| Filed 2022-09-01 20:30 Tx date 2022-08-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$48,169
+3,900 vol $12.35 each |
||
| Filed 2022-09-01 20:30 Tx date 2022-08-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,900 vol |
||
| Filed 2022-09-01 20:30 Tx date 2022-08-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,900 vol |
||
| Filed 2022-09-01 20:29 Tx date 2022-08-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$48,169
+3,900 vol $12.35 each |
||
| Filed 2022-08-26 18:06 Tx date 2022-08-25 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,100,000
-175,000 vol $12.00 each |
50,000 | |
| Filed 2022-08-04 12:43 Tx date 2022-07-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2022-08-04 12:42 Tx date 2022-07-27 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,245
+100 vol $12.45 each |
100 | |
| Filed 2022-08-04 12:42 Tx date 2022-07-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-300 vol |
0 | |
| Filed 2022-08-04 12:41 Tx date 2022-07-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,795
+300 vol $12.65 each |
300 | |
| Filed 2022-08-04 12:40 Tx date 2022-07-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2022-08-04 12:40 Tx date 2022-07-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,865
+500 vol $11.73 each |
500 | |
| Filed 2022-08-04 12:39 Tx date 2022-07-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-08-04 12:39 Tx date 2022-07-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,760
+2,000 vol $11.88 each |
2,000 | |
| Filed 2022-08-04 12:38 Tx date 2022-07-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,100 vol |
0 | |
| Filed 2022-08-04 12:38 Tx date 2022-07-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,288
+1,100 vol $12.08 each |
1,100 | |
| Filed 2022-08-04 12:37 Tx date 2022-07-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-08-04 12:37 Tx date 2022-07-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,480
+1,000 vol $11.48 each |
1,000 | |
| Filed 2022-08-04 12:36 Tx date 2022-07-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-08-04 12:36 Tx date 2022-07-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,900
+1,000 vol $11.90 each |
1,000 | |
| Filed 2022-08-04 12:35 Tx date 2022-07-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-08-04 12:35 Tx date 2022-07-15 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,600
+2,000 vol $11.80 each |
2,000 | |
| Filed 2022-08-04 12:34 Tx date 2022-07-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2022-08-04 12:34 Tx date 2022-07-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,875
+500 vol $11.75 each |
500 | |
| Filed 2022-08-04 12:33 Tx date 2022-07-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,500 vol |
0 | |
| Filed 2022-08-04 12:32 Tx date 2022-07-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,460
+1,500 vol $11.64 each |
1,500 | |
| Filed 2022-08-04 12:31 Tx date 2022-07-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-08-04 12:31 Tx date 2022-07-12 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,750
+1,000 vol $11.75 each |
1,000 | |
| Filed 2022-08-04 12:29 Tx date 2022-07-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-08-04 12:29 Tx date 2022-07-11 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,850
+1,000 vol $11.85 each |
1,000 | |
| Filed 2022-08-04 12:28 Tx date 2022-07-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-08-04 12:27 Tx date 2022-07-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,750
+1,000 vol $11.75 each |
1,000 | |
| Filed 2022-08-04 12:26 Tx date 2022-07-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-4,500 vol |
0 | |
| Filed 2022-08-04 12:26 Tx date 2022-07-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$52,020
+4,500 vol $11.56 each |
4,500 | |
| Filed 2022-08-04 12:25 Tx date 2022-07-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-08-04 12:25 Tx date 2022-07-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,250
+1,000 vol $12.25 each |
1,000 | |
| Filed 2022-07-08 12:15 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-07-08 12:15 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,500
+1,000 vol $12.50 each |
1,000 | |
| Filed 2022-07-08 12:14 Tx date 2022-06-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-07-08 12:13 Tx date 2022-06-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,760
+2,000 vol $12.88 each |
2,000 | |
| Filed 2022-07-08 12:12 Tx date 2022-06-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-07-08 12:12 Tx date 2022-06-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,000
+1,000 vol $12.00 each |
1,000 | |
| Filed 2022-07-08 12:11 Tx date 2022-06-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,500 vol |
0 | |
| Filed 2022-07-08 12:10 Tx date 2022-06-23 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,350
+2,500 vol $12.14 each |
2,500 | |
| Filed 2022-07-08 12:09 Tx date 2022-06-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-07-08 12:09 Tx date 2022-06-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,250
+1,000 vol $12.25 each |
1,000 | |
| Filed 2022-07-08 12:08 Tx date 2022-06-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-07-08 12:07 Tx date 2022-06-21 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,040
+2,000 vol $12.52 each |
2,000 | |
| Filed 2022-07-08 12:06 Tx date 2022-06-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-4,500 vol |
0 | |
| Filed 2022-07-08 12:06 Tx date 2022-06-20 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$58,005
+4,500 vol $12.89 each |
4,500 | |
| Filed 2022-07-08 12:05 Tx date 2022-06-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-07-08 12:04 Tx date 2022-06-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,340
+2,000 vol $12.67 each |
2,000 | |
| Filed 2022-07-08 12:03 Tx date 2022-06-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,000 vol |
0 | |
| Filed 2022-07-08 12:03 Tx date 2022-06-14 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$39,450
+3,000 vol $13.15 each |
3,000 | |
| Filed 2022-07-08 12:02 Tx date 2022-06-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2022-07-08 12:01 Tx date 2022-06-13 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,875
+500 vol $13.75 each |
500 | |
| Filed 2022-07-08 12:01 Tx date 2022-06-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-07-08 12:00 Tx date 2022-06-08 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,880
+2,000 vol $13.94 each |
2,000 | |
| Filed 2022-07-08 11:59 Tx date 2022-06-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2022-07-08 11:59 Tx date 2022-06-06 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,250
+500 vol $14.50 each |
500 | |
| Filed 2022-07-05 15:12 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,200
+1,456 vol $12.50 each |
17,708 | |
| Filed 2022-07-05 15:10 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,987
+1,519 vol $12.50 each |
17,918 | |
| Filed 2022-07-05 15:09 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$10,287
+823 vol $12.50 each |
15,605 | |
| Filed 2022-07-05 15:06 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,550
+364 vol $12.50 each |
14,081 | |
| Filed 2022-07-05 15:03 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$25,200
+2,016 vol $12.50 each |
21,749 | |
| Filed 2022-06-22 11:51 Tx date 2022-06-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,967 | ||
| Filed 2022-06-22 10:38 Tx date 2022-05-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2022-06-22 10:38 Tx date 2022-05-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,845
+500 vol $13.69 each |
500 | |
| Filed 2022-06-22 10:37 Tx date 2022-05-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,100 vol |
0 | |
| Filed 2022-06-22 10:37 Tx date 2022-05-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$29,400
+2,100 vol $14.00 each |
2,100 | |
| Filed 2022-06-22 10:36 Tx date 2022-05-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,000 vol |
0 | |
| Filed 2022-06-22 10:35 Tx date 2022-05-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$40,440
+3,000 vol $13.48 each |
3,000 | |
| Filed 2022-06-22 10:35 Tx date 2022-05-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-400 vol |
0 | |
| Filed 2022-06-22 10:34 Tx date 2022-05-19 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,044
+400 vol $12.61 each |
400 | |
| Filed 2022-06-22 10:33 Tx date 2022-05-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,300 vol |
0 | |
| Filed 2022-06-22 10:33 Tx date 2022-05-18 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$41,184
+3,300 vol $12.48 each |
3,300 | |
| Filed 2022-06-22 10:32 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200 vol |
0 | |
| Filed 2022-06-22 10:31 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,480
+200 vol $12.40 each |
200 | |
| Filed 2022-06-22 10:30 Tx date 2022-05-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-06-22 10:30 Tx date 2022-05-16 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,450
+1,000 vol $12.45 each |
1,000 | |
| Filed 2022-06-22 10:29 Tx date 2022-05-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2022-06-22 10:28 Tx date 2022-05-09 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,625
+500 vol $13.25 each |
500 | |
| Filed 2022-06-22 10:27 Tx date 2022-05-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-06-22 10:27 Tx date 2022-05-05 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,500
+1,000 vol $13.50 each |
1,000 | |
| Filed 2022-06-22 10:26 Tx date 2022-05-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2022-06-22 10:26 Tx date 2022-05-04 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,750
+500 vol $13.50 each |
500 | |
| Filed 2022-06-22 10:24 Tx date 2022-05-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-06-22 10:24 Tx date 2022-05-03 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,540
+1,000 vol $13.54 each |
1,000 | |
| Filed 2022-06-22 10:23 Tx date 2022-05-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
0 | |
| Filed 2022-06-22 10:22 Tx date 2022-05-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,180
+2,000 vol $13.59 each |
2,000 | |
| Filed 2022-06-22 10:21 Tx date 2022-04-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-600 vol |
0 | |
| Filed 2022-06-22 10:20 Tx date 2022-04-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,136
+600 vol $13.56 each |
600 | |
| Filed 2022-06-22 10:18 Tx date 2022-02-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
0 | |
| Filed 2022-06-22 10:15 Tx date 2022-02-02 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,750
+1,000 vol $13.75 each |
1,000 | |
| Filed 2022-06-22 10:13 Tx date 2022-02-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,750
+1,000 vol $13.75 each |
||
| Filed 2022-06-22 10:05 Tx date 2022-02-22 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,750
+1,000 vol $13.75 each |
||
| Filed 2022-06-22 10:03 Tx date 2021-12-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-800 vol |
0 | |
| Filed 2022-06-22 10:03 Tx date 2021-12-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,952
+800 vol $14.94 each |
800 | |
| Filed 2022-06-22 10:01 Tx date 2021-12-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-18 16:01 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,245
+500 vol $12.49 each |
47,500 | |
| Filed 2022-05-18 16:00 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,470
+1,000 vol $12.47 each |
47,000 | |
| Filed 2022-05-18 16:00 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,904
+800 vol $12.38 each |
46,000 | |
| Filed 2022-05-18 15:59 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,478
+200 vol $12.39 each |
45,200 | |
| Filed 2022-05-13 16:04 Tx date 2022-05-12 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-625,710
-50,000 vol $12.51 each |
838,575 | |
| Filed 2022-04-04 09:59 Tx date 2022-03-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,116
+1,211 vol $14.96 each |
16,252 | |
| Filed 2022-04-04 09:56 Tx date 2022-03-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,532
+303 vol $14.96 each |
13,717 | |
| Filed 2022-03-18 15:13 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-387,486
-19,800 vol $19.57 each |
1,062,450 | |
| Filed 2019-11-19 10:44 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-385,529
-19,700 vol $19.57 each |
||
| Filed 2022-03-16 12:34 Tx date 2021-08-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-137,647.40
-7,733 vol $17.80 each |
926,879 | |
| Filed 2022-03-16 12:31 Tx date 2021-08-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-137,349.50
-7,738 vol $17.75 each |
934,612 | |
| Filed 2021-08-26 09:56 Tx date 2021-08-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,647.40
-2,733 vol $17.80 each |
||
| Filed 2021-08-26 09:56 Tx date 2021-08-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,599.50
-2,738 vol $17.75 each |
||
| Filed 2022-01-11 15:44 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,905
+1,252 vol $15.10 each |
15,136 | |
| Filed 2022-01-11 15:43 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,416
+1,013 vol $18.18 each |
1,013 | |
| Filed 2022-01-11 15:39 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$27,557
+1,825 vol $15.10 each |
17,890 | |
| Filed 2022-01-11 15:34 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$26,870
+1,478 vol $18.18 each |
1,478 | |
| Filed 2021-12-13 17:03 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,489
+962 vol $18.18 each |
||
| Filed 2021-12-13 16:38 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$14,071
+774 vol $18.18 each |
||
| Filed 2022-01-10 16:46 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$10,237
+678 vol $15.10 each |
14,098 | |
| Filed 2022-01-10 16:42 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,104
+1,199 vol $15.10 each |
15,041 | |
| Filed 2022-01-10 16:39 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,530
+300 vol $15.10 each |
13,414 | |
| Filed 2021-12-16 12:13 Tx date 2021-12-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,399
+100 vol $13.99 each |
45,000 | |
| Filed 2021-12-16 12:13 Tx date 2021-12-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,600
+900 vol $14.00 each |
44,900 | |
| Filed 2021-12-14 15:20 Tx date 2020-06-25 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-65,000 vol |
0 | |
| Filed 2021-12-14 15:19 Tx date 2019-06-25 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-65,000 vol |
||
| Filed 2021-12-14 15:17 Tx date 2020-06-25 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-65,000 vol |
0 | |
| Filed 2021-12-14 15:16 Tx date 2019-06-25 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-195,000 vol |
65,000 | |
| Filed 2021-12-14 15:14 Tx date 2019-06-25 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-65,000 vol |
||
| Filed 2021-12-14 15:13 Tx date 2019-06-25 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-195,000 vol |
65,000 | |
| Filed 2021-12-14 15:12 Tx date 2019-06-25 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
+195,000 vol |
||
| Filed 2021-12-14 15:06 Tx date 2019-06-25 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
+195,000 vol |
||
| Filed 2021-12-14 13:34 Tx date 2020-06-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-65,000 vol |
0 | |
| Filed 2021-12-14 13:34 Tx date 2019-06-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-195,000 vol |
65,000 | |
| Filed 2021-12-14 13:28 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,840
+400 vol $14.60 each |
44,000 | |
| Filed 2021-12-14 13:27 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,820
+400 vol $14.55 each |
43,600 | |
| Filed 2021-12-14 13:26 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,377
+300 vol $14.59 each |
43,200 | |
| Filed 2021-12-14 13:25 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,852
+400 vol $14.63 each |
42,900 | |
| Filed 2021-12-14 13:22 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$85,614
+5,852 vol $14.63 each |
||
| Filed 2021-12-14 13:22 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,860
+4,377 vol $14.59 each |
||
| Filed 2021-12-14 13:20 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,860
+4,377 vol $14.59 each |
||
| Filed 2021-12-14 13:19 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$85,614
+5,852 vol $14.63 each |
||
| Filed 2021-12-13 17:12 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
12,871 | |
| Filed 2021-12-13 17:11 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 17:09 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
12,871 | |
| Filed 2021-12-13 17:09 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 17:07 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
12,871 | |
| Filed 2021-12-13 17:06 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 17:04 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
13,833 | |
| Filed 2021-12-13 17:03 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,489
+962 vol $18.18 each |
962 | |
| Filed 2021-12-13 17:02 Tx date 2021-06-18 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 17:00 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
13,420 | |
| Filed 2021-12-13 17:00 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$9,980
+549 vol $18.18 each |
549 | |
| Filed 2021-12-13 16:58 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 16:56 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
13,842 | |
| Filed 2021-12-13 16:55 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,652
+971 vol $18.18 each |
971 | |
| Filed 2021-12-13 16:54 Tx date 2019-03-21 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 16:52 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
13,114 | |
| Filed 2021-12-13 16:51 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,417
+243 vol $18.18 each |
243 | |
| Filed 2021-12-13 16:49 Tx date 2021-06-18 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 16:41 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$217,054
+14,587 vol $14.88 each |
15,361 | |
| Filed 2021-12-13 16:38 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$14,071
+774 vol $18.18 each |
774 | |
| Filed 2021-12-13 16:34 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-10 15:05 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$23,130
+2,313 vol $10.00 each |
7,313 | |
| Filed 2021-12-10 15:04 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,497
+3,342 vol $15.11 each |
15,482 | |
| Filed 2021-12-10 15:02 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$28,000
+2,800 vol $10.00 each |
14,800 | |
| Filed 2021-12-10 15:00 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$61,135
+4,046 vol $15.11 each |
27,766 | |
| Filed 2021-12-10 14:58 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$47,470
+4,747 vol $10.00 each |
22,747 | |
| Filed 2021-12-10 14:57 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,639
+6,859 vol $15.11 each |
121,643 | |
| Filed 2021-12-10 14:54 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$150,060
+15,006 vol $10.00 each |
33,006 | |
| Filed 2021-12-10 14:53 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$327,660
+21,685 vol $15.11 each |
70,454 | |
| Filed 2021-12-10 14:50 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$284,590
+28,459 vol $10.00 each |
46,459 | |
| Filed 2021-12-10 14:49 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$621,398
+41,125 vol $15.11 each |
117,999 | |
| Filed 2021-12-10 14:46 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$387,660
+38,766 vol $10.00 each |
58,766 | |
| Filed 2021-12-10 14:45 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$846,462
+56,020 vol $15.11 each |
169,087 | |
| Filed 2021-12-10 14:41 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$321,200
+32,120 vol $10.00 each |
52,120 | |
| Filed 2021-12-10 14:40 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$701,360
+46,417 vol $15.11 each |
142,294 | |
| Filed 2021-12-10 14:37 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$1,392,410
+139,241 vol $10.00 each |
459,241 | |
| Filed 2021-12-10 14:36 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,040,358
+201,215 vol $15.11 each |
720,461 | |
| Filed 2021-12-10 14:32 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$512,660
+51,266 vol $10.00 each |
351,266 | |
| Filed 2021-12-10 14:28 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,119,409
+74,084 vol $15.11 each |
442,377 | |
| Filed 2021-12-08 15:12 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-450,000
-30,000 vol $15.00 each |
898,675 | |
| Filed 2021-12-08 15:09 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$75,325
+5,000 vol $15.06 each |
25,000 | |
| Filed 2021-09-21 15:32 Tx date 2021-09-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$104,250
+12,500 vol $8.34 each |
42,500 | |
| Filed 2021-09-21 15:28 Tx date 2021-09-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-104,250
-12,500 vol $8.34 each |
95,877 | |
| Filed 2021-08-31 08:52 Tx date 2021-08-27 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-92,500
-5,000 vol $18.50 each |
928,675 | |
| Filed 2021-08-31 08:51 Tx date 2021-08-27 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-91,750
-5,000 vol $18.35 each |
933,675 | |
| Filed 2021-08-31 08:50 Tx date 2021-08-27 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,304
-2,128 vol $18.00 each |
938,675 | |
| Filed 2021-08-31 08:49 Tx date 2021-08-27 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$32,726
+3,924 vol $8.34 each |
940,803 | |
| Filed 2021-08-31 08:48 Tx date 2021-08-27 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,726.16
-3,924 vol $8.34 each |
368,293 | |
| Filed 2021-08-31 08:44 Tx date 2021-08-27 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,825,090
-100,000 vol $18.25 each |
225,000 | |
| Filed 2021-08-26 09:56 Tx date 2021-08-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,647.40
-2,733 vol $17.80 each |
936,879 | |
| Filed 2021-08-26 09:56 Tx date 2021-08-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,599.50
-2,738 vol $17.75 each |
939,612 | |
| Filed 2021-08-26 09:55 Tx date 2021-08-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$83,400
+10,000 vol $8.34 each |
942,350 | |
| Filed 2021-08-26 09:53 Tx date 2021-08-25 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-83,400
-10,000 vol $8.34 each |
372,217 | |
| Filed 2021-08-23 08:52 Tx date 2021-08-20 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-137,322.50
-7,847 vol $17.50 each |
932,350 | |
| Filed 2021-08-23 08:51 Tx date 2021-08-20 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$65,443
+7,847 vol $8.34 each |
940,197 | |
| Filed 2021-08-23 08:49 Tx date 2021-08-20 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-65,443.98
-7,847 vol $8.34 each |
382,217 | |
| Filed 2021-08-20 12:28 Tx date 2021-08-20 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,000
+2,000 vol $17.50 each |
20,000 | |
| Filed 2021-08-19 15:42 Tx date 2021-08-19 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-172,658
-10,000 vol $17.27 each |
932,350 | |
| Filed 2021-06-24 12:27 Tx date 2021-06-18 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500 | ||
| Filed 2021-06-18 09:30 Tx date 2021-06-16 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-340,800
-20,000 vol $17.04 each |
942,350 | |
| Filed 2021-06-18 09:28 Tx date 2021-06-16 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$166,800
+20,000 vol $8.34 each |
962,350 | |
| Filed 2021-06-18 09:26 Tx date 2021-06-16 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-166,800
-20,000 vol $8.34 each |
390,064 | |
| Filed 2021-05-27 11:00 Tx date 2021-05-05 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
| Filed 2021-05-27 10:59 Tx date 2021-05-05 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,140 | ||
| Filed 2021-05-21 14:48 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,100
+300 vol $17.00 each |
30,000 | |
| Filed 2021-05-21 14:47 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,576
+800 vol $16.97 each |
29,700 | |
| Filed 2021-05-21 14:46 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,352
+1,200 vol $16.96 each |
28,900 | |
| Filed 2021-05-21 14:44 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,379
+200 vol $16.90 each |
27,700 | |
| Filed 2021-05-21 14:43 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,865
+700 vol $16.95 each |
27,500 | |
| Filed 2021-05-21 14:41 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,073
+300 vol $16.91 each |
26,800 | |
| Filed 2021-05-21 14:40 Tx date 2021-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,800
+1,000 vol $16.80 each |
26,500 | |
| Filed 2021-05-17 09:42 Tx date 2021-05-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,720
+100 vol $17.20 each |
25,500 | |
| Filed 2021-05-17 09:42 Tx date 2021-05-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,952
+400 vol $17.38 each |
25,400 | |
| Filed 2021-05-17 09:41 Tx date 2021-05-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,478
+200 vol $17.39 each |
25,000 | |
| Filed 2021-05-14 09:18 Tx date 2021-05-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+600 vol $17.50 each |
24,800 | |
| Filed 2021-05-14 09:17 Tx date 2021-05-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,004
+400 vol $17.51 each |
24,200 | |
| Filed 2021-05-14 09:17 Tx date 2021-05-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,915
+500 vol $17.83 each |
23,800 | |
| Filed 2021-05-14 09:16 Tx date 2021-05-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,556
+200 vol $17.78 each |
23,300 | |
| Filed 2021-05-14 09:16 Tx date 2021-05-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,775
+100 vol $17.75 each |
23,100 | |
| Filed 2021-04-05 08:16 Tx date 2021-03-31 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-489,000
-25,000 vol $19.56 each |
325,000 | |
| Filed 2021-04-02 07:49 Tx date 2021-03-30 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,000,200
-50,000 vol $20.00 each |
350,000 | |
| Filed 2021-03-19 08:41 Tx date 2021-03-17 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
12,000 | ||
| Filed 2021-03-19 08:40 Tx date 2021-03-17 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
23,720 | ||
| Filed 2020-12-23 11:43 Tx date 2020-12-23 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,190,000
-70,000 vol $17.00 each |
400,000 | |
| Filed 2020-11-20 16:36 Tx date 2020-11-19 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-892,500
-52,500 vol $17.00 each |
470,000 | |
| Filed 2020-11-20 16:35 Tx date 2020-11-19 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,507,500
-147,500 vol $17.00 each |
0 | |
| Filed 2020-11-18 16:33 Tx date 2020-11-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,400
+1,000 vol $15.40 each |
23,000 | |
| Filed 2020-11-17 12:29 Tx date 2020-03-03 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-762,356.30
-47,030 vol $16.21 each |
605,598 | |
| Filed 2020-11-17 12:28 Tx date 2020-02-27 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,658.95
-235 vol $15.57 each |
652,628 | |
| Filed 2020-11-17 12:28 Tx date 2020-03-03 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,286,906.80
-141,080 vol $16.21 each |
1,816,803 | |
| Filed 2020-11-17 12:27 Tx date 2020-02-27 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,992.42
-706 vol $15.57 each |
1,957,883 | |
| Filed 2020-11-17 12:26 Tx date 2020-03-03 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-192,736.90
-11,890 vol $16.21 each |
51,214 | |
| Filed 2020-11-17 12:24 Tx date 2020-02-27 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-918.63
-59 vol $15.57 each |
63,104 | |
| Filed 2020-11-17 12:21 Tx date 2020-08-11 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-63,193 vol |
135,836 | |
| Filed 2020-11-17 12:21 Tx date 2020-08-11 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-189,578 vol |
407,507 | |
| Filed 2020-11-17 12:20 Tx date 2020-08-11 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-63,193 vol |
135,836 | |
| Filed 2020-11-13 14:58 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$180,000
+18,000 vol $10.00 each |
18,000 | |
| Filed 2020-11-13 14:58 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 14:56 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$180,000
+18,000 vol $10.00 each |
18,000 | |
| Filed 2020-11-13 14:56 Tx date 2018-05-07 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 14:54 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$180,000
+18,000 vol $10.00 each |
18,000 | |
| Filed 2020-11-13 14:54 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 14:52 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$200,000
+20,000 vol $10.00 each |
20,000 | |
| Filed 2020-11-13 14:51 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 14:50 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$200,000
+20,000 vol $10.00 each |
20,000 | |
| Filed 2020-11-13 14:49 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 14:48 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$600,000
+60,000 vol $10.00 each |
320,000 | |
| Filed 2020-11-13 14:46 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$450,000
+45,000 vol $10.00 each |
305,000 | |
| Filed 2020-11-13 14:44 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$400,000
+40,000 vol $10.00 each |
300,000 | |
| Filed 2020-11-13 12:47 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$233,400
+15,000 vol $15.56 each |
48,769 | |
| Filed 2020-11-13 12:45 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$186,720
+12,000 vol $15.56 each |
76,874 | |
| Filed 2020-11-13 12:44 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
114,784 | |
| Filed 2020-11-13 12:41 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$389,000
+25,000 vol $15.56 each |
108,377 | |
| Filed 2020-11-13 12:40 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$389,000
+25,000 vol $15.56 each |
113,067 | |
| Filed 2020-11-13 12:38 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,011,400
+65,000 vol $15.56 each |
519,246 | |
| Filed 2020-11-13 12:37 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$758,550
+48,750 vol $15.56 each |
502,996 | |
| Filed 2020-11-13 12:35 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$622,400
+40,000 vol $15.56 each |
410,064 | |
| Filed 2020-11-13 12:32 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
30,254 | |
| Filed 2020-11-13 12:31 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
30,254 | |
| Filed 2020-11-13 12:29 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
21,695 | |
| Filed 2020-11-13 12:27 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
86,674 | |
| Filed 2020-11-13 12:24 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$186,720
+12,000 vol $15.56 each |
94,004 | |
| Filed 2020-11-11 08:02 Tx date 2020-11-10 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-158,400
-9,900 vol $16.00 each |
942,350 | |
| Filed 2020-11-09 11:12 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$131,200
+8,000 vol $16.40 each |
18,000 | |
| Filed 2020-01-17 21:16 Tx date 2020-01-15 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+226,782 vol |
4,351,782 | |
| Filed 2020-01-17 21:16 Tx date 2020-01-15 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-525,409 vol |
0 | |
| Filed 2020-01-07 17:15 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
199,029 | |
| Filed 2020-01-07 17:13 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.47
+63,163 vol $0.009 each |
652,863 | |
| Filed 2020-01-07 17:12 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-1,706.184
-189,576 vol $0.009 each |
597,085 | |
| Filed 2020-01-07 17:10 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$1,705
+189,489 vol $0.009 each |
1,958,589 | |
| Filed 2020-01-07 17:07 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
199,029 | |
| Filed 2020-01-07 17:06 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.47
+63,163 vol $0.009 each |
63,163 | |
| Filed 2019-12-20 16:12 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,191,400
-220,600 vol $19.00 each |
2,138,210 | |
| Filed 2019-12-20 16:11 Tx date 2019-12-18 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,105,367.50
-369,110 vol $19.25 each |
1,769,100 | |
| Filed 2019-12-20 16:10 Tx date 2019-12-18 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,369,213
-123,076 vol $19.25 each |
589,700 | |
| Filed 2019-12-20 16:10 Tx date 2019-12-18 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,102,062.50
-57,250 vol $19.25 each |
0 | |
| Filed 2019-12-20 16:09 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,396,500
-73,500 vol $19.00 each |
712,776 | |
| Filed 2019-12-20 16:08 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-112,100
-5,900 vol $19.00 each |
57,250 | |
| Filed 2019-12-20 16:07 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,522.40
-80 vol $19.03 each |
2,358,810 | |
| Filed 2019-12-20 16:06 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-380.60
-20 vol $19.03 each |
786,276 | |
| Filed 2019-12-09 13:49 Tx date 2019-12-05 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,745
+100 vol $17.45 each |
49,700 | |
| Filed 2019-12-09 13:49 Tx date 2019-12-05 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,761
+100 vol $17.61 each |
49,600 | |
| Filed 2019-11-21 16:46 Tx date 2019-11-21 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,525,678.44
-87,100 vol $17.52 each |
952,250 | |
| Filed 2019-11-21 12:28 Tx date 2019-11-19 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-177,446.62
-9,400 vol $18.88 each |
1,039,350 | |
| Filed 2019-11-20 17:54 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
786,296 | |
| Filed 2019-11-20 17:53 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
262,221 | |
| Filed 2019-11-20 17:51 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$1,705
+189,450 vol $0.009 each |
2,358,890 | |
| Filed 2019-11-20 17:50 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-1,706.184
-189,576 vol $0.009 each |
786,661 | |
| Filed 2019-11-20 17:47 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
63,150 | |
| Filed 2019-11-20 17:46 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
262,221 | |
| Filed 2019-11-20 17:45 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
||
| Filed 2019-11-20 17:44 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
||
| Filed 2019-11-20 17:43 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
||
| Filed 2019-11-20 17:43 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
||
| Filed 2019-11-20 17:41 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
||
| Filed 2019-11-20 17:37 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
||
| Filed 2019-11-19 10:45 Tx date 2019-11-18 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-269,870.04
-13,800 vol $19.56 each |
1,048,750 | |
| Filed 2019-11-19 10:44 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-385,529
-19,700 vol $19.57 each |
1,062,550 | |
| Filed 2019-09-06 16:21 Tx date 2019-09-05 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,087,457.50
-673,145 vol $13.50 each |
0 | |
| Filed 2019-08-30 15:16 Tx date 2019-08-30 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,750
+500 vol $13.50 each |
500 | |
| Filed 2019-08-30 15:16 Tx date 2018-05-07 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-21 18:28 Tx date 2019-08-16 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-700,000
-50,000 vol $14.00 each |
673,145 | |
| Filed 2019-08-21 18:27 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$1,894
+189,440 vol $0.01 each |
2,169,440 | |
| Filed 2019-08-21 18:26 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$631.46
+63,146 vol $0.01 each |
723,146 | |
| Filed 2019-08-21 18:24 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$631.46
+63,146 vol $0.01 each |
723,145 | |
| Filed 2019-08-21 18:23 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-1,895.76
-189,576 vol $0.01 each |
976,237 | |
| Filed 2019-08-21 18:19 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
325,413 | |
| Filed 2019-08-21 18:18 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
325,413 | |
| Filed 2019-08-21 18:17 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:17 Tx date 2019-08-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:16 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:15 Tx date 2019-08-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:14 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:13 Tx date 2019-08-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-20 12:44 Tx date 2019-08-19 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,620
+3,000 vol $14.54 each |
522,500 | |
| Filed 2019-08-19 14:47 Tx date 2019-08-19 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,045
+4,900 vol $14.30 each |
10,000 | |
| Filed 2019-08-19 14:46 Tx date 2019-08-19 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,415
+100 vol $14.15 each |
5,100 | |
| Filed 2019-08-16 15:31 Tx date 2019-08-16 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$280,000
+20,000 vol $14.00 each |
1,082,250 | |
| Filed 2019-08-14 08:49 Tx date 2019-08-12 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$155,000
+10,000 vol $15.50 each |
1,062,250 | |
| Filed 2019-06-11 11:00 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$189,150
+12,164 vol $15.55 each |
33,769 | |
| Filed 2019-06-11 10:59 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$361,832
+23,269 vol $15.55 each |
64,874 | |
| Filed 2019-06-11 10:57 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$187,361
+12,049 vol $15.55 each |
104,784 | |
| Filed 2019-06-11 10:54 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Daughtery, Carmel Maria
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$201,854
+12,981 vol $15.55 each |
42,217 | |
| Filed 2019-06-11 10:53 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$434,140
+27,919 vol $15.55 each |
88,067 | |
| Filed 2019-06-11 10:51 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$659,615
+42,419 vol $15.55 each |
83,377 | |
| Filed 2019-06-11 10:49 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,661,144
+106,826 vol $15.55 each |
454,246 | |
| Filed 2019-06-11 10:47 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$949,498
+61,061 vol $15.55 each |
370,064 | |
| Filed 2019-06-11 10:45 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,857
+11,695 vol $15.55 each |
20,254 | |
| Filed 2019-06-11 10:43 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,857
+11,695 vol $15.55 each |
20,254 | |
| Filed 2019-06-11 10:41 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,857
+11,695 vol $15.55 each |
11,695 | |
| Filed 2019-06-11 10:40 Tx date 2019-03-21 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-11 10:39 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,857
+11,695 vol $15.55 each |
76,674 | |
| Filed 2019-06-11 10:36 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$229,720
+14,773 vol $15.55 each |
82,004 | |
| Filed 2019-06-11 10:34 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,661,144
+106,826 vol $15.55 each |
454,246 | |
| Filed 2019-06-07 12:28 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,100,000
-200,000 vol $15.50 each |
1,052,250 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$180,185
+21,605 vol $8.34 each |
41,605 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$784,894
+94,112 vol $8.34 each |
347,420 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,163
+10,811 vol $8.34 each |
67,231 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$784,894
+94,112 vol $8.34 each |
347,420 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Tasse, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,382
+8,559 vol $8.34 each |
8,559 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,509
+28,958 vol $8.34 each |
40,958 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$464,496
+55,695 vol $8.34 each |
309,003 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$141,571
+16,975 vol $8.34 each |
92,735 | |
| Filed 2018-08-23 Tx date 2018-05-07 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Daughtery, Carmel Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$177,108
+21,236 vol $8.34 each |
29,236 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,382
+8,559 vol $8.34 each |
8,559 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,382
+8,559 vol $8.34 each |
64,979 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Lennox, Ryan Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$180,185
+21,605 vol $8.34 each |
21,605 | |
| Filed 2018-08-23 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-23 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Tasse, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-23 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$225,405
+27,027 vol $8.34 each |
60,148 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,382
+8,559 vol $8.34 each |
8,559 | |
| Filed 2018-05-31 Tx date 2018-05-31 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,104
+9,990 vol $9.52 each |
1,252,250 | |
| Filed 2018-05-29 Tx date 2018-05-28 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$93.00
+10 vol $9.30 each |
1,242,260 | |
| Filed 2018-05-24 Tx date 2018-05-24 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,790
+300 vol $9.30 each |
300 | |
| Filed 2018-05-24 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-05-24 Tx date 2018-05-24 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,280
+1,200 vol $9.40 each |
1,500 | |
| Filed 2018-05-24 Tx date 2018-05-24 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,250
+3,500 vol $9.50 each |
5,000 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+660,000 vol |
660,000 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,980,000 vol |
1,980,000 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+659,999 vol |
659,999 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+388,605 vol |
388,605 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,165,813 vol |
1,165,813 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+388,605 vol |
388,605 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+525,409 vol |
525,409 | |
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+4,125,000 vol |
4,125,000 | |
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
260,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
22,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
56,420 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
MacLean, Joseph Anthony
5 - Senior Officer of Issuer
Holder: AOI Capital LLC (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,902,250 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Seide, Rochelle Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
33,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
MacLean, Joseph Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
260,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
MacLean, Joseph Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
253,308 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
260,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
253,308 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Wells, William M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,242,250 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Sharma, Sanjiv
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
33,121 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Seide, Rochelle Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
42,350 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
56,420 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Daughtery, Carmel Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Daughtery, Carmel Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
8,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Holder: Kingsbarn Ventures, LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
902,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
253,308 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
260,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
49,500 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
75,760 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
147,500 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
519,500 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
253,308 |